2024 International Conference on Communication Networks and Software Engineering (ICCNSE 2024) will be held on December 26-28, 2024 in Shenyang, China. This conference aims to provide a comprehensive global forum for experts and scholars to share their latest research findings, ideas, and development...
NSE新闻|我院博士研究生郑雅文荣获高水平国际会议Graduate Award奖项 2024年12月12日至14日,墨尔本实证贸易会议 (Melbourne Empirical Trade Conference, METC) 在澳大利亚墨尔本顺利举办。作为实证国际贸易研究的顶级会议之一,本次会议由莫纳什...
10 December 2024 Aeronautica Militare at NSE 2024: Advancing Space and Aerospace Innovation 10 December 2024 NSE Expoforum on board of the Space Golden League 30 January 2025 INGV at the European Forum on the New Space Economy to Celebrate… Space!
Ranked 3rd in NIRF India Rankings 2024, IIMK has gained global recognition, ranking #68 in FT Masters in Management 2024 and #70 in FT Open Enrollment 2024. It is globally accredited by EQUIS and AMBA.Key themes for the conference Transformative Finance for Growth Amid Disruptions Ameliorating ...
摘要 目的:探讨大鼠血清髓鞘碱性蛋白(myelin basic protein,MBP)、神经元特异性烯醇化酶(neuron-specificenolase,NSE)及S100蛋白在反映亚急性1,2-二氯乙烷(1,2-dichloroethame,1,2-DCE)中毒中的价值,为监测1,2-DCE作业人群职业健康及职业中毒防治提供参考依据. 方法:采用健康的SPF级别SD成年大鼠48只,雌雄各半,随...
著录项 会议地点杭州 作者单位 中国科学技术协会; 会议组织 正文语种 原文格式PDF 中图分类颅脑;法医鉴定学; 入库时间2024-12-27 03:57:32
参考文献[1]ShekDTL.InternationalConferenceonTacklingDrugAbuse-ConferenceProceedings[C].HongKong,NarcoticsDivision,SecurityBureau,GovernmentoftheHongKongSpecMiAdministrativeRegion,2006.[2]刘俊彪.止咳药水滥用者得调查与分析[J].中国民康医学,2009,16(21):2024-2025[3]劳永志,蒋泽宇,童梓顺,等.170例滥用止咳水患者...
01.11.2024 T-box Workshop: “Leveraging Generative AI Technology to Capture New Business Opportunities” 4-5 NOV Hong Kong 04.11.2024 - 05.11.2024 Hong Kong International Computer Conference 2024 5-10 NOV Mainland China 05.11.2024 - 10.11.2024 ...
后来该成果发表在“计算机视觉与模式识别”会议(Conference on Computer Vision and Pattern Recognition,简称CVPR)上,随后我们举办了首届统计建模与随机计算工作坊(First Int'l Workshop on Statistical and Computational Theories of Vision - Modeling, Learning, Computing, and Sampling),来者也多是学统计出身的学者...
在刚刚落幕的2024年美国临床肿瘤学会(ASCO)年会上,多项国产抗肿瘤创新药研究成功跻身“重磅研究摘要”(Late-Breaking Abstract, LBA)之列,彰显了重要的临床价值和开创性意义,其中就包括KRAS G12C抑制剂氟泽雷塞(Fulzerasib)联合西妥昔单抗一线治疗KRAS G12C突变晚期非小细胞肺癌(NSCLC)的KROCUS研究(摘要号LBA8511...